These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4831987)

  • 1. Anti-arrhythmic effect of oxyfedrin.
    Eichbaum FW; Yasaka WJ
    Eur J Pharmacol; 1974 Apr; 26(1):82-8. PubMed ID: 4831987
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiarrhythmic activity of 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
    Kato H; Noguchi Y; Takagi K
    Jpn J Pharmacol; 1974 Aug; 24(4):589-9. PubMed ID: 4455968
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(5):566-70. PubMed ID: 5364670
    [No Abstract]   [Full Text] [Related]  

  • 4. [Stimulation, stimulus conduction and myocardial excitability of the human heart under oxyfedrin therapy of bradycardic dysrhythmias (author's transl)].
    Diewitz M
    Med Klin; 1974 May; 69(18):806-13. PubMed ID: 4151986
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of propafenon in experimentally digitalis glycoside-induced arrhythmia].
    Germiniani H; Branco Germiniani CD; Iark FB; do Pillar MD
    Arq Bras Cardiol; 1979 Jul; 33(1):77-83. PubMed ID: 526179
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

  • 7. [The anti-arrhythmic activity of EDTA tetrabutylamide].
    Gendenshteĭn EI
    Biull Eksp Biol Med; 1966 Jul; 62(7):71-3. PubMed ID: 4988482
    [No Abstract]   [Full Text] [Related]  

  • 8. Antifibrillatory effect of beta-adrenergic agonists.
    Eichbaum FW; Yasaka WJ; Bruno Z
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(3):313-7. PubMed ID: 4147375
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-arrhythmic effect of nadolol in experimental arrhythmias: comparison with propranolol and alprenolol.
    Nakashima M; Takiguchi Y; Oguro K; Sogabe K; Hashimoto H
    J Pharmacobiodyn; 1985 Jan; 8(1):1-10. PubMed ID: 4009395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-arrhythmic action of dilazep. Action on experimental arrhythmias induced by g-strophanthin (ouabain), epinephrine and aconitine.
    Sano N; Kawada M; Fukutomi Y
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1893-8. PubMed ID: 4141624
    [No Abstract]   [Full Text] [Related]  

  • 12. Esmolol prevents and suppresses arrhythmias during halothane anaesthesia in dogs.
    Dimich I; Lingham R; Narang J; Sampson I; Shiang H
    Can J Anaesth; 1992 Jan; 39(1):83-6. PubMed ID: 1346371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-arrhythmic effects of propafenone in coronary patients with ventricular arrhythmias].
    Fiol M; Palma JL; Bayés de Luna A; Aza V; Sadurní J
    Rev Esp Cardiol; 1984; 37(3):196-200. PubMed ID: 6505351
    [No Abstract]   [Full Text] [Related]  

  • 14. [Propafenone: a new anti-arrhythmic agent for the treatment of ventricular ectopic beats].
    Molinis G; Valente M; Tuniz D; Maisano G
    Cardiologia; 1982; 27(2):211-7. PubMed ID: 6927434
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of lithium hydroxybutyrate and lithium chloride on heart rhythm disorders of various origins].
    Galenko-Iaroshevskiĭ PA; Shadurskiĭ KS; Tikhonov AV
    Farmakol Toksikol; 1984; 47(4):54-9. PubMed ID: 6090202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The anti-arrhythmic effects and electrophysiological actions of propafenone].
    Zheng DS; Wang BY
    Zhonghua Yi Xue Za Zhi; 1985 Jul; 65(7):418-20. PubMed ID: 3938327
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oral propafenone in chronic ventricular arrhythmias. Prospective evaluation with the Holter monitor].
    Sánchez Domínguez J; Roldán I; Navarro A; Villa JG; Urbina FJ; Barciela R; Barras C
    Rev Clin Esp; 1985 Nov; 177(8):372-5. PubMed ID: 3836459
    [No Abstract]   [Full Text] [Related]  

  • 18. [Propafenone, a new anti arrhythmic agent].
    Ruipérez Abizanda JA; Campos Peris JV; Ruiz Ros JA; García García J; Jaen Armand E; Marco Quiles J; Martínez Jerez M; Salas Nieto J; Rodríguez Ruiz P; Pico Aracil F
    Rev Clin Esp; 1980 Sep; 158(6):279-81. PubMed ID: 7010468
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 4th communication: influence on experimentally induced ventricular arrhythmia in dogs.
    Yoshimura A; Yoshioka K; Hino M; Sugawara H; Sakato M; Endoh M
    Arzneimittelforschung; 1999 May; 49(5):420-6. PubMed ID: 10367104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.